Physician profile
John J Holtzman
NPI 1851361133
$128,567.63
in general payments reported to CMS, 2019-2025
26 companies · $23K in 2025
The $23K reported for 2025 was more than what 98% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $695 · 2020: $1,249 · 2021: $20K · 2022: $47K · 2023: $12K · 2024: $24K · 2025: $23K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $40K · Travel and Lodging: $12K · Food and Beverage: $7,268.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $40,150.00 |
| Travel and Lodging | $12,318.02 |
| Food and Beverage | $7,268.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Triad Life Sciences INC. | $60,818.97 | 2021-2022 | |
| Convatec INC. | $56,027.72 | 2023-2025 | |
| Elite Orthopedics, LLC | $6,302.07 | 2020-2025 | |
| Stryker Corporation | $3,819.96 | 2019-2025 | Infinity Adaptis, Anchorage, Citrefix |
| Smith+Nephew, INC. | $318.93 | 2019-2025 | Collagenase Santyl, Grafix Pl, Stravix |
| Ets Wound Care LLC | $241.76 | 2024 | Mirragen Advanced Wound Matrix |
| Acera Surgical, INC. | $158.65 | 2019 | |
| Choice Spine, LLC | $150.52 | 2021 | |
| Maruho Medical, INC. | $100.21 | 2021 | |
| Reprise Biomedical, INC. | $89.84 | 2025 | Miro3d |
| Organogenesis INC. | $68.11 | 2023 | Affinity, Puraply |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $60.93 | 2020-2023 | Jublia |
| Medtronic, INC. | $56.75 | 2022-2023 | Vanta Adaptivestim |
| Linvatec Corporation | $54.84 | 2025 | Biobrace 23mm |
| Acumed LLC | $51.81 | 2024 | Acumed |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $43.68 | 2019-2020 | |
| Tei Medical INC. | $28.61 | 2019 | |
| Biowound Solutions, INC. | $27.06 | 2025 | Bio-Connekt |
| Solventum Corporation | $23.81 | 2025 | V.A.C. Veraflo, Prevena, V.A.C.Ulta |
| Bioventus LLC | $22.43 | 2024 | Exogen Ultrasound Bone Healing System |
| Kerecis Limited | $19.43 | 2022 | |
| Paratek Pharmaceuticals, INC. | $18.24 | 2025 | Nuzyra |
| Pierre Fabre Pharmaceuticals, INC. | $18.03 | 2019 | |
| Amgen INC. | $16.54 | 2025 | Krystexxa |
| Averitas Pharma INC. | $15.26 | 2023 | Qutenza |
| Wright Medical Technology, INC. | $13.47 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Holtzman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.